Abstract:Objective The incidence of acute pulmonary injury occurred after cardiopulmonary bypass for fallot tetrad has been high. The severity of pulmonary ischemia-reperfusion has been found to be reduced with ulinastatin (UTI) in the animal models and clinical practice. We evaluated the effect of pulmonary artery perfusion with a hypothermic protective solution containing ulinastatin on the inflammatory response in the lung during cardiopulmonary bypass. Methods 30 children with tetralogy of Fallot (TOF) were randomly assigned into control group and protective group, 15 cases in each group. Patients would be excluded if they had signs of infections, such as the white blood cell count was over 12000 per microliter, the temperature was above 38 centi-degree and the c-reaction protein was more than 8 mg/L. Operation with routine approaches was performed in the control group and the pulmonary artery was infused with 4℃ protective solution in the protective group while the heart stoped beating. Plasma tumor necrosis factor α (TNF-α) 、CD11b and Myeloperoxidase (MPO) were measured intraoperatively and postoperatively. Blood gas、pulmonary function and clinic index of the patients were also monitored. Results The level of TNF-α was lower in the protective group as compared with that in the control group immediately and 3 hours after closing the sternum [(11.15±2.47) pg/ml vs. (14.21 ±5.55) pg/ml, P<0.05; (12.01 ±2.69) pg/ml vs. (15.94 ±4.86)pg/ml,P <0.01]. The MFI of CD11b was lower in the protective group as compared with that in the control group at 3 and 6 hoursafter closing the sternum (126.23±36.05 vs. 156.98±48.34, P<0.05; 137.27±38.85 vs. 173.27±67.43, P<0.05). The level of MPO was lower in protective group as compared with that in the control group at 3 hours, 6 hours and 24hours after closing the sternum [(156.52±17.57)U/L vs.(178.45±35.68)U/L, P<0.05; (178.28±23.63) U/L vs.(224.66±49.66)U/L, P<0.01;(130.52±57.50)U/L vs. (96.50±14.49)U/L, P<0.05]. The duration of mechanical ventilation was significantly shorter in the protective group than that in the control group (17.60±6.39 vs. 23.70±8.51,P<0.05). Alveolar-arterial oxygen pressure difference (A-aDO2, calculated as [FiO2×713-5/4×PaCO2]-PaO2) in the protective group was less than that in the control group at 3 and 6 hours after closing the sternum [(120.92±33.08)mm Hg vs. (145.52±39.38)mmHg, P<0.05;(74.76±40.16)mm Hg vs. (112.50±44.16)mmHg, P<0.01]. Dynamic compliance (Cdyn) in protective group was lower than that in control group at 3 and 6 hours after closing the sternum [(0.59±0.11)ml·cmH2O-1·kg-1 vs. (0.46±0.17)ml·cmH2O-1·kg-1, P<0.05;(0.67±0.09)ml·cmH2O-1·kg-1vs. (0.53±0.18)ml·cmH2O-1·kg-1,P<0.05). Conclusion Perfusion with hypothermic protective solution containing UTI to the pulmonary artery during cardiopulmonary bypass may reduce the inflammatory responses substantially in the lung after bypass and had a role in the lung protection.

Effect of Ulinastatin on Expression of Inflammatory Cytokines During Perioperative Period of Surgical Correction of Adolescent Idiopathic Scoliosis

Effect of ulinastatin on expression of S100β protein and TNF-α in patients undergoing open-heart surgery with cardiopulmonary bypass

Effect of Ulinastatin on Neuron Apoptosis and CCAAT/enhancer-binding Protein Expression of Spinal Cord after Peripheral Nerve Injury

The protective role of hypothermic protective solution during surgey for the tetralogy of Fallot

A Preliminary Study of the Effects of Ulinastatin on Early Postoperative Cognition Function in Patients Undergoing Abdominal Surgery

[Effects of Ulinastatin on Cognitive Function in Patients with Coronary Artery Bypass Grafting].

Effects of ulinastatin on inflammatory reaction during perioperative pneumoperitoneum rectal cancer operation

Effects of Ulinastafin on Proinflammatory Cytokines and Oxygen Free Radicals During Orthotopic Liver Transplantation

Effects of Ulinastatin Pretreatment on the Lung Injury During One-Lung Ventilation

Effects of Ulinastatin on Peripheral Blood T Cell Subsets CD95 Expression and Plasma Sicam-1, IL-8 Levels During Perioperative Renal Transplantation

Effect of Ultrasound-Guided Stellate Ganglion Block on Perioperative Inflammatory Responses and Postoperative Recovery of Gastrointestinal Function in Patients Undergoing Gastrointestinal Surgery

The study of Ulinastatin's curative effect for the patient with sepsis after hepatobiliary surgery

Effects of ulinastatin on hepatorenal function and cellular immunity in patients undergoing thoracic surgery

Advantages of ulinastatin in the off-pump coronary artery bypass surgery

Relationship Between the Occurrence of Postoperative Cognitive Dysfunction and the Levels of Serum Interleukin-1 Beta/ Interleukin-6 During Perioperative Period in Idiopathic Adolescent Scoliosis Patients

Protective effects of Ulinastatin on lung injury in pediatric patients undergoing cardiopulmonary bypass

Ulinastatin in combination with aprotinin improves systemic inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass

Effect of Ulinastatin Combined with Pantoprazole on Inflammatory Factors and Gastrointestinal Tract in Patients Undergoing Cardiopulmonary Bypass Cardiac Surgery

Plasma Levels of Tumor Necrosis Factor-Α in Adolescent Idiopathic Scoliosis Patients Serve As a Predictor for the Incidence of Early Postoperative Cognitive Dysfunction Following Orthopedic Surgery.

Effect of Peritoneal Lavage with Ulinastatin on the Expression of NF-κB and TNF-α in Multiple Organs of Rats with Severe Acute Pancreatitis.

Effect of Ulinastatin on Heat Shock Protein 70 Expression in Rats with Septic Acute Lung Injury